You are here

Article info

Article menu
Download PDFPDF
Article
Advances in interleukin 2 receptor targeted treatment

Authors

  • John C Morris Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, NIH, Bldg 10, Rm 4N115, 10 Center Drive, Bethesda, MD 20892–1374, USA PubMed articlesGoogle scholar articles
  • Thomas A Waldmann Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, NIH, Bldg 10, Rm 4N115, 10 Center Drive, Bethesda, MD 20892–1374, USA PubMed articlesGoogle scholar articles
  1. Dr Morris (jmorris{at}mail.nih.gov)
View Full Text

Citation

Morris JC, Waldmann TA
Advances in interleukin 2 receptor targeted treatment
Annals of the Rheumatic Diseases 2000;59:i109-i114.

Publication history

  • First published November 1, 2000.
Online issue publication 
April 21, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Annals of the Rheumatic Diseases